help_outline
Skip to main content
Print This Page
Text Size
Scroll To Top
Add Me To Your Mailing List
Member Login
My Shopping Cart
Shopping Cart
cancel
Share This Page
Share this page on Facebook
Share this page on Linkedin
Share this page on Twitter
Home
About
Who We Are
Mission and Vision
Become a Member
Leadership
Committees
Storefront
Events
Past Events
Upcoming Events
Int'l. Palladium Medal
Othmer Gold Medal Award
Winthrop-Sears Award
Scholarship
Member Forums
Join
Contact
Home
Events
WEBINAR: Recombinant DNA and the Birth of Biotech - Chronicling 50 Years of a Disruptive Technology
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Events
- Event View
This is the "Event Detail" view, showing all available information for this event. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
Return to Grid View
Show Search
Today
WEBINAR: Recombinant DNA and the Birth of Biotech - Chronicling 50 Years of a Disruptive Technology
The March 20th webinar has been recorded. Members of Société can view the webinar
here
2023 marked the 50th anniversary of a scientific milestone—the initial generation of recombinant DNA (rDNA) by scientists at Stanford University and the University of California, San Francisco. Recombinant DNA and gene cloning technologies went on to foster important innovations in agriculture and drug development and catalyzed the emergence and growth of the biotechnology industry. But these revolutionary scientific developments also generated unprecedented levels of interest and scrutiny from journalists, policy makers, and members of the public who were fascinated—and occasionally disturbed!—by the potential of these groundbreaking technologies.
In this lecture, David Cole shares highlights from the history of rDNA, exploring its “origin story” and its emergence as a scientific, medical, industrial, and public phenomenon over the past fifty years. Informed by this history, he will also examine parallels between past debates around rDNA and gene cloning and currently developing discourses about the promise and ethics of CRISPR gene editing and AI-driven biomedicine
There is no question that recombinant DNA will continue to drive innovations for many years to come in both drug delivery, but also many other aspects of science and our lives.
Following the presentation, attendees will have the opportunity to participate in a 30 minute networking session.
Speaker:
David Allen Cole
President & CEO
Science History Institute
About our Speaker:
David Allen Cole
is the president and CEO of the Science History Institute in Philadelphia. Prior to arriving at the Institute in 2020, he had served as the Executive Director of the Hagley Museum and Library in Wilmington, Delaware since 2013. He is interested in innovation history and theory and is the author of The Power of Innovation, an exhibition and catalogue on the history of American invention and the U.S. patent system in the nineteenth century, presented at the National Museum of China (2018). A graduate of Vanderbilt University, he received a master’s degree from Harvard University and a Ph.D. in the History of Art and American Studies from the University of Texas at Austin. Dr. Cole has been a Henry Luce Foundation Fellow, a Research Fellow of the Learning Innovations Laboratory (LILA) of Harvard University, and has taught at Harvard University, Rice University, and the University of Texas at Austin.
When:
Wednesday, March 20, 2024, 1:00 PM until 2:30 PM
Additional Info:
Event Contact(s):
Danielle J Fraser
203-763-9255 (p)
Category:
Special Event
Registration is required
Payment In Full In Advance Only
Cancellation Policy:
Capacity:
0
Available Slots:
0
Filled
Member
$30.00
Guest of Member
$40.00
Guest
$40.00
Guest of a Non-Member
$40.00
Add to my Calendar
What is this?